Free Trial

Cogent Biosciences (COGT) SEC Filings & 10K Form

Cogent Biosciences logo
$8.00 -0.09 (-1.11%)
Closing price 04:00 PM Eastern
Extended Trading
$7.99 -0.01 (-0.12%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cogent Biosciences SEC Filings

DateFilerForm TypeView
02/10/2025
4:20 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
JB CAPITAL PARTNERS LP (Filed by)
Form SCHEDULE 13G/A
01/22/2025
8:50 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
GEYGAN JAMES (Reporting)
GEYGAN JEFFREY RICHART (Reporting)
Geygan Kathleen (Reporting)
GLOBAL VALUE INVESTMENT CORP. (Reporting)
Rice Shawn G (Reporting)
Wilke Stacy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:02 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
Form SCHEDULE 13D/A
01/17/2025
1:05 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:16 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
1:58 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
11:10 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4/A
12/06/2024
11:11 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
12/06/2024
11:12 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4/A
12/06/2024
11:13 AM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4/A
12/04/2024
1:33 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
1:35 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
1:37 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
1:43 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:49 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
GEYGAN JAMES (Reporting)
GEYGAN JEFFREY RICHART (Reporting)
Geygan Kathleen (Reporting)
GLOBAL VALUE INVESTMENT CORP. (Reporting)
Rice Shawn G (Reporting)
Wilke Stacy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/03/2024
4:15 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
Form SC 13D/A
12/02/2024
5:40 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 424B5
12/02/2024
5:03 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:32 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form NT 10-Q
11/15/2024
3:30 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/11/2024
4:36 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
1:26 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
11:15 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form EFFECT
08/27/2024
8:00 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/26/2024
4:18 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
Form SC 13D/A
08/23/2024
3:35 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
Form SC 13D/A
08/23/2024
3:36 PM
Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Form SC 13D/A
08/21/2024
1:24 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
10:59 AM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:01 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:03 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:04 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
11:20 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q/A
08/19/2024
4:13 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
3:27 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
4:01 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form NT 10-Q
07/22/2024
3:52 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
Form SC 13D/A
07/17/2024
5:20 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:00 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
11:40 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
2:49 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The FED is losing the war on inflation (Ad)

It's no longer just a “guesstimate” – Inflation is indeed getting worse. And although we want to believe the Fed has a good grip on it, they don't. Right now, the suits over there are caught between a rock and a hard place. Either they watch as inflation grows, or they tear it down and send us into a full-blown recession. The kicker here is that neither of these are good for you. Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower. The only real way out for the regular person is to increase your earning power. By increasing your income to match prices as they flare up… You’ll stay ahead of the impending doom we're running face-first into. And if you're looking for a strategy to help increase your income in 2025… I've got just the thing for you! You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts But I changed my trading rules and more than doubled my results on those 100 published trades. I'm now calling them Warped Options…

You can go here to give yourself a head start.
07/08/2024
2:51 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
11:15 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:06 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
SHATTUCK KOHN BARBARA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:10 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Mathis Donald H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:13 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Graff David Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:15 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
PFENNIGER RICHARD C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
7:53 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:54 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:55 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:56 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:57 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:45 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
06/18/2024
3:43 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
11:14 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form DEFA14A
06/07/2024
10:35 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
4:27 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form DEF 14A
05/30/2024
3:45 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
05/23/2024
4:19 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form PRE 14A
05/20/2024
4:28 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
Form SC 13D/A
05/16/2024
7:02 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
11:21 AM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
Form SC 13D/A
05/16/2024
11:22 AM
Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Form SC 13D/A
05/15/2024
8:55 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:30 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:50 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
3:18 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
4:22 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
4:21 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form ARS
04/02/2024
3:21 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
4:18 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
5:01 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:57 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
5:16 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
5:17 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
5:26 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:43 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
4:41 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
4:43 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:23 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:24 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
03/06/2024
5:25 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:25 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
11:05 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:COGT) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners